MorphoSys
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public, Subsidiary
- Established
- 1992-01-01
- Employees
- 524
- Market Cap
- $2.8B
- Website
- http://www.morphosys.de
- Introduction
MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in different areas of unmet medical need. Tremfya (guselkumab) - ...
Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid Arthritis
- First Posted Date
- 2009-12-02
- Last Posted Date
- 2014-10-24
- Lead Sponsor
- MorphoSys AG
- Target Recruit Count
- 96
- Registration Number
- NCT01023256
- Locations
- 🇺🇦
MorphoSys Investigative sites, MorphoSys investigatíve sites, Ukraine
© Copyright 2024. All Rights Reserved by MedPath